Nina Bhardwaj
Affiliations: | Basic Medical Science | New York University, New York, NY, United States |
Area:
Cell Biology, Microbiology Biology, Molecular BiologyGoogle:
"Nina Bhardwaj"Children
Sign in to add trainee| Kira Minkis | grad student | 2008 | NYU |
| Rachel L. Sabado | grad student | 2009 | NYU |
| Alice W. Yewdall | grad student | 2009 | NYU |
| Dusan Bogunovic | grad student | 2010 | NYU |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Anker J, Pal SK, Kim-Schulze S, et al. (2023) Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. Journal For Immunotherapy of Cancer. 11 |
| Brown M, Tran MA, Bhardwaj N. (2023) Cancer immunity derailed: PGE misconducts cDC1s. Immunity. 56: 1165-1167 |
| Mestrallet G, Sone K, Bhardwaj N. (2022) Strategies to overcome DC dysregulation in the tumor microenvironment. Frontiers in Immunology. 13: 980709 |
| Salomé B, Sfakianos JP, Ranti D, et al. (2022) NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. Cancer Cell. 40: 1027-1043.e9 |
| Gigoux M, Holmström MO, Zappasodi R, et al. (2022) Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science Translational Medicine. 14: eaba4380 |
| Cimen Bozkus C, Blazquez AB, Enokida T, et al. (2021) A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses. Star Protocols. 2: 100758 |
| Weingarten-Gabbay S, Klaeger S, Sarkizova S, et al. (2021) Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell |
| Li MO, Wolf N, Raulet DH, et al. (2021) Innate immune cells in the tumor microenvironment. Cancer Cell. 39: 725-729 |
| Bhardwaj N, Friedlander PA, Pavlick AC, et al. (2020) Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets. Nature Cancer. 1: 1204-1217 |
| Sfakianos JP, Salome B, Daza J, et al. (2020) Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. Urologic Oncology |